CC BY-NC-ND 4.0 · Sleep Sci 2023; 16(01): 068-074
DOI: 10.1055/s-0043-1767757
Original Article

Association of Sleep Duration and Use of Sleeping Medication with Multimorbidity in Adults: Results from the PAMPA (Brazil) Cohort Study

1   Federal University of Pelotas, Postgraduate Program in Nursing, Pelotas, Rio Grande do Sul, Brazil
2   University of São Paulo, Postgraduate Program in Nursing in Public Health, São Paulo, São Paulo, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
,
2   University of São Paulo, Postgraduate Program in Nursing in Public Health, São Paulo, São Paulo, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
,
1   Federal University of Pelotas, Postgraduate Program in Nursing, Pelotas, Rio Grande do Sul, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
,
3   Federal University of Pelotas, Postgraduate Program in Physical Education, Pelotas, Rio Grande do Sul, Brazil
› Author Affiliations

Abstract

Objective To analyze the association of sleep duration and use of sleeping medication with multimorbidity.

Materials and Methods We conducted a cross-sectional study using data from the Prospective Study about Mental and Physical Health (PAMPA) cohort. Multimorbidity was defined as the presence of two or more conditions from a list of twelve health problems. Descriptive analyses were performed considering proportion and its 95% confidence interval (95%CI). We performed logistic regression (to obtain odds ratios, ORs) to estimate the associations, including models adjusted for confounding factors.

Results In total, 2,936 participants were included, 79,1% of them women, 54.2% aged between 18 and 39 years, and 88.9% with white skin color. Compared with regular sleep (seven to eight hours a day), five hours or less of sleep increased the odds of multimorbidity by 145% (95%CI: 1.90–3.14), and 9 hours or more of sleep increased the odds by 49% (95%CI: 1.14–1.95) for the crude model; the results remained significant even in the adjusted models.

Discussion Consumption of sleeping medication was associated with multimorbidity. Short and prolonged sleep duration increased the odds of multimorbidity, regardless of the sociodemographic and behavior characteristics. The regular use of sleeping medication was also associated with multimorbidity. The results of the present study are important but require caution due to reverse causality, and longitudinal studies are needed to confirm the findings.



Publication History

Received: 12 February 2022

Accepted: 14 July 2022

Article published online:
19 April 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 WHO. Multimorbidity. Technical Series on Safer Primary Care. World Health Organization; 2016. .
  • 2 Nguyen H, Manolova G, Daskalopoulou C, Vitoratou S, Prince M, Prina AM. Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies. J Comorb 2019; 9: X19870934.
  • 3 Nicholson K, Almirall J, Fortin M. The measurement of multimorbidity. Health Psychol 2019; 38 (09) 783-790 https://pubmed.ncbi.nlm.nih.gov/31021126/ cited 2022May30 [Internet].
  • 4 De Carvalho JN, Roncalli ÂG, De Camargo Cancela M, De Souza DLB. Prevalence of multimorbidity in the Brazilian adult population according to socioeconomic and demographic characteristics. PLoS One 2017;12(04).
  • 5 Rzewuska M, de Azevedo-Marques JM, Coxon D. et al. Epidemiology of multimorbidity within the Brazilian adult general population: Evidence from the 2013 National Health Survey (PNS 2013). PLoS One 2017; 12 (02) e0171813.
  • 6 Nunes BP, Batista SRR, Andrade FB, Souza Junior PRB, Lima-Costa MF, Facchini LA. Multimorbidity: The Brazilian Longitudinal Study of Aging (ELSI-Brazil). Rev Saude Publica 2018; 52(52, Suppl 2)10s. cited 2021Aug18 [Internet] http://www.scielo.br/j/rsp/a/SpVZJRr9zsQGJ3SYVb7qwHt/?lang=en.
  • 7 Delpino FM, Wendt A, Crespo PA, Blumenberg C, Teixeira DS da C, Batista SR, Malta DC, Miranda JJ, Flores TR, Nunes BP, Wehrmeister FC. et al. Ocorrência e desigualdades por escolaridade em multimorbidade em adultos brasileiros entre 2013 e 2019: evidências da Pesquisa Nacional de Saúde. Revista Brasileira de Epidemiologia 2021; 2021-2030 DOI: 10.1590/1980-549720210016.SUPL.2..
  • 8 King DE, Xiang J, Pilkerton CS. DE K. Multimorbidity Trends in United States Adults, 1988-2014. J Am Board Fam Med 2018; 31 (04) 503-513.
  • 9 van Oostrom SH, Gijsen R, Stirbu I. et al. Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: Data from general practices and health surveys. PLoS One 2016; 11 (08) e0160264 . [Internet]. cited 2021Apr2 DOI: 10.17026/dans-zrm-7r4z..
  • 10 Arokiasamy P, Uttamacharya U, Jain K. et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal?. BMC Med 2015; 13 (01) 178.
  • 11 Zheng DD, Loewenstein DA, Christ SL. et al. Multimorbidity patterns and their relationship to mortality in the US older adult population. PLoS One 2021; 16 (01) e0245053.
  • 12 Chudasama YV, Gillies CL, Zaccardi F. et al. Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes Metab Syndr 2020; 14 (05) 965-967.
  • 13 Stenholm S, Head J, Kivimäki M. et al. Sleep Duration and Sleep Disturbances as Predictors of Healthy and Chronic Disease-Free Life Expectancy Between Ages 50 and 75: A Pooled Analysis of Three Cohorts. J Gerontol A Biol Sci Med Sci 2019; 74 (02) 204-210.
  • 14 von Ruesten A, Weikert C, Fietze I, Boeing H. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS One 2012; 7 (01) e30972.
  • 15 Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010; 33 (05) 585-592.
  • 16 Yin J, Jin X, Shan Z. et al. Relationship of sleep duration with all-cause mortality and cardiovascular events: A systematic review and dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc 2017; 6 (09) e005947.
  • 17 de Morais LC, Zanuto EAC, Queiroz DC, Araújo MYC, Rocha APR, Codogno JS. Association between sleep disorders and chronic diseases in patients of the Brazilian national health system. J Phys Educ 2017; 28 (01) 2844.
  • 18 Lima MG, Barros MBA, Ceolim MF, Zancanella E, Cardoso TAMO. Sleep duration, health status, and subjective well-being: a population-based study. Rev Saude Publica 2018; 52: 82-91.
  • 19 Pinto J, van Zeller M, Amorim P. et al. Sleep quality in times of Covid-19 pandemic. Sleep Med 2020; 74: 81-85.
  • 20 Robbins R, Affouf M, Weaver MD. et al. Estimated sleep duration before and during the COVID-19 pandemic in major metropolitan areas on different continents: Observational study of smartphone app data. J Med Internet Res 2021; 23 (02) e20546.
  • 21 Feter N, Caputo EL, Doring IR. et al. Longitudinal study about low back pain, mental health, and access to healthcare system during COVID-19 pandemic: Protocol of an ambispective cohort. medRxiv. 2020 Jul 24;2020.07.22.20160309.
  • 22 Enes CC, Nucci LB. A Telephone Surveillance System for Noncommunicable Diseases in Brazil. Public Health Rep 2019; 134 (04) 324-327.
  • 23 Ruiz-Castell M, Makovski TT, Bocquet V, Stranges S. Sleep duration and multimorbidity in Luxembourg: results from the European Health Examination Survey in Luxembourg, 2013-2015. BMJ Open 2019; 9 (08) e026942 http://bmjopen.bmj.com/ cited 2021Jun29 [Internet].
  • 24 Nicholson K, Rodrigues R, Anderson KK, Wilk P, Guaiana G, Stranges S. Sleep behaviours and multimorbidity occurrence in middle-aged and older adults: findings from the Canadian Longitudinal Study on Aging (CLSA). Sleep Med 2020; 75: 156-162 https://europepmc.org/article/med/32858355 cited 2021Jun29 [Internet].
  • 25 Sindi S, Pérez LM, Vetrano DL. et al. Sleep disturbances and the speed of multimorbidity development in old age: results from a longitudinal population-based study. BMC Med 2020; 18 (01) 382 https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01846-w cited 2021Jul30 [Internet].
  • 26 Helbig AK, Stöckl D, Heier M. et al. Relationship between sleep disturbances and multimorbidity among community-dwelling men and women aged 65-93 years: results from the KORA Age Study. Sleep Med 2017; 33: 151-159.
  • 27 Al Lawati NM, Patel SR, Ayas NT. Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration. Prog Cardiovasc Dis 2009; 51 (04) 285-293.
  • 28 He L, Biddle SJH, Lee JT. et al. The prevalence of multimorbidity and its association with physical activity and sleep duration in middle aged and elderly adults: a longitudinal analysis from China. Int J Behav Nutr Phys Act 2021; 18 (01) 77 https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01150-7 cited 2021Aug10 [Internet].
  • 29 Medic G, Wille M, Hemels MEH. Short- and long-term health consequences of sleep disruption. Nat Sci Sleep 2017; 9: 151-161.
  • 30 Reddy S, Sharma S. Physiology, Circadian Rhythm. Stat Pearls; 2019. .
  • 31 Patke A, Young MW, Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms. Nat Rev Mol Cell Biol 2020; 21 (02) 67-84.
  • 32 Ferrie JE, Shipley MJ, Akbaraly TN, Marmot MG, Kivimäki M, Singh-Manoux A. Change in sleep duration and cognitive function: findings from the Whitehall II Study. Sleep 2011; 34 (05) 565-573.
  • 33 Alhola P, Polo-Kantola P. Sleep deprivation: Impact on cognitive performance. Neuropsychiatr Dis Treat 2007; 3 (05) 553-567.
  • 34 Krause AJ, Simon EB, Mander BA. et al. The sleep-deprived human brain. Nat Rev Neurosci 2017; 18 (07) 404-418.
  • 35 Cappuccio FP, Taggart FM, Kandala NB. et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008; 31 (05) 619-626.
  • 36 Taheri S. The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity. Arch Dis Child 2006; 91 (11) 881-884.
  • 37 St-Onge MP, Mikic A, Pietrolungo CE. Effects of diet on sleep quality. Adv Nutr 2016; 7 (05) 938-949.
  • 38 Rusch HL, Rosario M, Levison LM. et al. The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Ann N Y Acad Sci 2019; 1445 (01) 5-16.
  • 39 Banno M, Harada Y, Taniguchi M. et al. Exercise can improve sleep quality: a systematic review and meta-analysis. PeerJ 2018; 6 (07) e5172.
  • 40 Mendes Delpino FI, Lucia Caputo EI, Cozzensa da Silva III M, Fossati Reichert FI, Pereira Nunes Bv, Feter NV. et al. Incidence of multimorbidity and associated factors during the COVID-19 pandemic in Brazil: a cohort study. Sao Paulo Medical Journal [Internet]. 2022 Apr 29 [cited 2022 May 30];140(3):447–53. Available from: http://www.scielo.br/j/spmj/a/tH4HFs4LzJH6BHbb86TtWfw/?lang=en.
  • 41 Ferreira CRT, Leitão FNC, de Deus MBB, Bezerra IMP, de Deus RRB, de Deus Morais MJ. A qualidade do sono durante o distanciamento domiciliar na pandemia do COVID-19 na Amazônia ocidental. J Hum Growth Dev 2021; 31 (03) 458-464 . cited 2022 May 30 [Internet]. Available from http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822021000300010&lng=pt&nrm=iso&tlng=pt.
  • 42 Barros Mde A, Lima MG, Malta DC, Szwarcwald CL, Azevedo Rde, Romero D. et al. Relato de tristeza/depressão, nervosismo/ansiedade e problemas de sono na população adulta brasileira durante a pandemia de COVID-19. Epidemiologia e Serviços de Saúde [Internet]. 2020 [cited 2022 May 30];29(4):e2020427. Available from: http://scielo.iec.gov.br/scielo.php?script=sci_arttext&pid=S1679-49742020000400021&lng=pt&nrm=iso&tlng=pt.